Nephron Invests $215m In South Carolina’s Lexington County

Company Adds Vaccine Production Space

Nephron Pharma has announced major expansion in South Carolina’s Lexington County through investment projects involving a new vaccine production space. Nephron’s $215m investment comes after the company invested $313m in its headquarters and production facility in South Carolina.

Small tree
Nephron announces expansion and investment projects • Source: Shutterstock

South Carolina’s Nephron Pharmaceuticals Corporation- known for developing and producing affordable generic inhalation solutions and suspension products, including those used to treat severe respiratory distress symptoms associated with COVID-19 - has announced an investment of $215m in Lexington County which will help the company add a new vaccine production space, apart from a new office and warehouse, in the county’s Saxe-Gotha Industrial Park.

Henry McMaster, Governor of South Carolina commented, “This new investment of more than $215m creating 380 new jobs (by 2024)...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business